Rockland Immunochemicals
Private Company
Funding information not available
Overview
Rockland Immunochemicals is a mature, revenue-generating provider of antibodies and specialized research services, leveraging over 60 years of experience in immunochemistry. The company has evolved from a traditional antibody supplier into a specialized partner for the rapidly growing RNA therapeutics field, offering innovative tools like its sequence-independent ModDetect™ panels for nucleic acid modification detection. Its business model combines the sale of catalog reagents with high-margin custom antibody development, protein characterization, and assay development services, positioning it as an enabler for both academic research and biopharmaceutical R&D.
Technology Platform
Proprietary immunochemistry and hybridoma development for antibody production, combined with the ModDetect™ platform for sequence-independent detection of nucleic acid modifications in oligonucleotides.
Opportunities
Risk Factors
Competitive Landscape
Rockland competes in the broad life science research tools market against giants like Thermo Fisher Scientific, Abcam, and Bio-Techne, as well as numerous niche antibody producers. Its differentiation lies in its deep custom service capabilities, long-standing reputation for quality, and its novel focus on immunoassays for oligonucleotide analysis, a less crowded segment compared to traditional antibody reagents.